{"DataElement":{"publicId":"4986297","version":"1","preferredName":"Stomach Neuroendocrine Tumor American Joint Committee on Cancer (AJCC) Edition 7 Clinical Tumor T Stage","preferredDefinition":"Extent of the primary gastric neuroendocrine tumor based on evidence obtained from clinical assessment parameters determined prior to treatment.","longName":"4985365v1.0:4985913v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"4985365","version":"1","preferredName":"Gastric Neuroendocrine Tumor Clinical T Stage","preferredDefinition":"A well differentiated, low or intermediate grade tumor with neuroendocrine differentiation that arises from the stomach._Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"4985973v1.0:2207100v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"4985973","version":"1","preferredName":"Gastric Neuroendocrine Tumor","preferredDefinition":"A well differentiated, low or intermediate grade tumor with neuroendocrine differentiation that arises from the stomach.","longName":"C95871","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Neuroendocrine Tumor","conceptCode":"C95871","definition":"A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E394406-99BC-29FD-E050-BB89AD437682","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207100","version":"1","preferredName":"Clinical T Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25398:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-183F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E29E3CB-E149-8112-E050-BB89AD432902","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created per request by COG for their APEC14B1 study in Rave. mc 8/25/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4985913","version":"1","preferredName":"Gastric Neuroendocrine Tumor American Joint Committee on Cancer (AJCC) Edition 7 T Stage","preferredDefinition":"A well differentiated, low or intermediate grade tumor with neuroendocrine differentiation that arises from the stomach._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"4985913v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T0","valueDescription":"Gastric Neuroendocrine Tumor pT0 TNM Finding v7","ValueMeaning":{"publicId":"4985915","version":"1","preferredName":"Gastric Neuroendocrine Tumor pT0 TNM Finding v7","longName":"4985915","preferredDefinition":"Gastric neuroendocrine tumor with no evidence of a primary tumor. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Neuroendocrine Tumor pT0 TNM Finding v7","conceptCode":"C90070","definition":"Gastric neuroendocrine tumor with no evidence of a primary tumor. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3891DB-F82E-17E5-E050-BB89AD433150","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3891DB-F847-17E5-E050-BB89AD433150","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"},{"value":"T1","valueDescription":"Gastric Neuroendocrine Tumor pT1 TNM Finding v7","ValueMeaning":{"publicId":"4985917","version":"1","preferredName":"Gastric Neuroendocrine Tumor pT1 TNM Finding v7","longName":"4985917","preferredDefinition":"Gastric neuroendocrine tumor invading lamina propria or submucosa and is 1 cm or less in size. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Neuroendocrine Tumor pT1 TNM Finding v7","conceptCode":"C90072","definition":"Gastric neuroendocrine tumor invading lamina propria or submucosa and is 1 cm or less in size. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3891DB-F854-17E5-E050-BB89AD433150","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3891DB-F86D-17E5-E050-BB89AD433150","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"},{"value":"T2","valueDescription":"Gastric Neuroendocrine Tumor pT2 TNM Finding v7","ValueMeaning":{"publicId":"4985919","version":"1","preferredName":"Gastric Neuroendocrine Tumor pT2 TNM Finding v7","longName":"4985919","preferredDefinition":"Gastric neuroendocrine tumor invading muscularis propria or is more than 1 cm in size. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Neuroendocrine Tumor pT2 TNM Finding v7","conceptCode":"C90073","definition":"Gastric neuroendocrine tumor invading muscularis propria or is more than 1 cm in size. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3891DB-F87A-17E5-E050-BB89AD433150","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3891DB-F893-17E5-E050-BB89AD433150","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"},{"value":"T3","valueDescription":"Gastric Neuroendocrine Tumor pT3 TNM Finding v7","ValueMeaning":{"publicId":"4985921","version":"1","preferredName":"Gastric Neuroendocrine Tumor pT3 TNM Finding v7","longName":"4985921","preferredDefinition":"Gastric neuroendocrine tumor penetrating subserosa.  (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Neuroendocrine Tumor pT3 TNM Finding v7","conceptCode":"C90074","definition":"Gastric neuroendocrine tumor penetrating subserosa.  (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3891DB-F8A0-17E5-E050-BB89AD433150","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3891DB-F8B9-17E5-E050-BB89AD433150","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"},{"value":"T4","valueDescription":"Gastric Neuroendocrine Tumor pT4 TNM Finding v7","ValueMeaning":{"publicId":"4985923","version":"1","preferredName":"Gastric Neuroendocrine Tumor pT4 TNM Finding v7","longName":"4985923","preferredDefinition":"Gastric neuroendocrine tumor invading visceral peritoneum (serosa) or other organs or adjacent structures. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Neuroendocrine Tumor pT4 TNM Finding v7","conceptCode":"C90075","definition":"Gastric neuroendocrine tumor invading visceral peritoneum (serosa) or other organs or adjacent structures. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3891DB-F8C6-17E5-E050-BB89AD433150","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3891DB-F8DF-17E5-E050-BB89AD433150","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"},{"value":"Tis","valueDescription":"Gastric Neuroendocrine Tumor pTis TNM Finding v7","ValueMeaning":{"publicId":"4985925","version":"1","preferredName":"Gastric Neuroendocrine Tumor pTis TNM Finding v7","longName":"4985925","preferredDefinition":"Gastric neuroendocrine tumor with a finding of carcinoma in situ/dysplasia (tumor size less than 0.5 mm), confined to mucosa. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Neuroendocrine Tumor pTis TNM Finding v7","conceptCode":"C90071","definition":"Gastric neuroendocrine tumor with a finding of carcinoma in situ/dysplasia (tumor size less than 0.5 mm), confined to mucosa. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3891DB-F8EC-17E5-E050-BB89AD433150","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3891DB-F905-17E5-E050-BB89AD433150","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"},{"value":"TX","valueDescription":"Gastric Neuroendocrine Tumor pTX TNM Finding v7","ValueMeaning":{"publicId":"4985927","version":"1","preferredName":"Gastric Neuroendocrine Tumor pTX TNM Finding v7","longName":"4985927","preferredDefinition":"Gastric neuroendocrine tumor in which the primary tumor cannot be assessed. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Neuroendocrine Tumor pTX TNM Finding v7","conceptCode":"C90068","definition":"Gastric neuroendocrine tumor in which the primary tumor cannot be assessed. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3891DB-F912-17E5-E050-BB89AD433150","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3891DB-F92B-17E5-E050-BB89AD433150","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4985912","version":"1","preferredName":"Gastric Neuroendocrine Tumor American Joint Committee on Cancer T Stage Stage","preferredDefinition":"A well differentiated, low or intermediate grade tumor with neuroendocrine differentiation that arises from the stomach.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C95871:C39315:C25728:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Neuroendocrine Tumor","conceptCode":"C95871","definition":"A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3891DB-F802-17E5-E050-BB89AD433150","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3891DB-F813-17E5-E050-BB89AD433150","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"COOPERM","dateModified":"2015-09-22","changeDescription":"Created per request by COG for their APEC14B1 study in Rave. mc 8/25/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"4985894","version":"1","longName":"Neuroendocrine","context":"NCIP"},{"publicId":"4985891","version":"1","longName":"Stomach","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5777526","version":"1","longName":"Neuroendocrine ","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical T Stage","type":"Preferred Question Text","description":"Clinical T Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"1E3B406F-4765-408D-E050-BB89AD430537","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"TAYLORT","dateModified":"2017-04-19","changeDescription":"Created by COG request for their APEC14B1 study in Rave. mc 8/26/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}